These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2146488)

  • 1. Differential inhibition of calcium-dependent and calmodulin-dependent enzymes by drug-calmodulin adducts.
    Zhang SP; Prozialeck WC; Weiss B
    Mol Pharmacol; 1990 Nov; 38(5):698-704. PubMed ID: 2146488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibition of calmodulin-sensitive phosphodiesterase and Ca++-adenosine triphosphatase by chlorpromazine-linked calmodulin.
    Prozialeck WC; Wallace TL; Weiss B
    J Pharmacol Exp Ther; 1987 Oct; 243(1):171-9. PubMed ID: 2822896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naphthalenesulfonamides as calmodulin antagonists and protein kinase inhibitors.
    Inagaki M; Kawamoto S; Itoh H; Saitoh M; Hagiwara M; Takahashi J; Hidaka H
    Mol Pharmacol; 1986 Jun; 29(6):577-81. PubMed ID: 2872589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calmodulin antagonistic action of KS-504a, a novel metabolite of the fungus Mollisia ventosa.
    Nakanishi S; Kuroda K; Osawa K; Kase H
    Agric Biol Chem; 1990 Oct; 54(10):2697-702. PubMed ID: 1369297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of calmodulin function and of Ca2+-induced smooth muscle contraction by the calmodulin antagonist, HT-74.
    Tanaka T; Umekawa H; Saitoh M; Ishikawa T; Shin T; Ito M; Itoh H; Kawamatsu Y; Sugihara H; Hidaka H
    Mol Pharmacol; 1986 Mar; 29(3):264-9. PubMed ID: 3005834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable conformation and dynamics of calmodulin complexed with peptides derived from the autoinhibitory domains of target proteins.
    Yao Y; Squier TC
    Biochemistry; 1996 May; 35(21):6815-27. PubMed ID: 8639633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the calmodulin antagonist, fluphenazine, on phosphorylation of myosin and phosphorylase in intact smooth muscle.
    Silver PJ; Stull JT
    Mol Pharmacol; 1983 May; 23(3):665-70. PubMed ID: 6688120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two types of calcium-dependent protein phosphorylations modulated by calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Yamakado T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):408-12. PubMed ID: 6897280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-dependent and -independent interactions of the calmodulin-binding domain of cyclic nucleotide phosphodiesterase with calmodulin.
    Yuan T; Walsh MP; Sutherland C; Fabian H; Vogel HJ
    Biochemistry; 1999 Feb; 38(5):1446-55. PubMed ID: 9931009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of calmodulin alters its potency as an activator of target enzymes.
    Quadroni M; L'Hostis EL; Corti C; Myagkikh I; Durussel I; Cox J; James P; Carafoli E
    Biochemistry; 1998 May; 37(18):6523-32. PubMed ID: 9572870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.
    Tanaka T; Ohmura T; Hidaka H
    Mol Pharmacol; 1982 Sep; 22(2):403-7. PubMed ID: 7144734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Mg2+-binding sites and the role of Mg2+ on target recognition by calmodulin.
    Ohki S; Ikura M; Zhang M
    Biochemistry; 1997 Apr; 36(14):4309-16. PubMed ID: 9100027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of calmodulin in the first calcium-binding pocket by myosin light chain kinase.
    Davis HW; Crimmins DL; Thoma RS; Garcia JG
    Arch Biochem Biophys; 1996 Aug; 332(1):101-9. PubMed ID: 8806714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of contractile activity in vascular smooth muscle by protein kinases.
    Silver PJ
    Rev Clin Basic Pharm; 1985; 5(3-4):341-95. PubMed ID: 3029813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fourth EF-hand of calmodulin and its helix-loop-helix components: impact on calcium binding and enzyme activation.
    George SE; Su Z; Fan D; Wang S; Johnson JD
    Biochemistry; 1996 Jun; 35(25):8307-13. PubMed ID: 8679587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutron-scattering studies reveal further details of the Ca2+/calmodulin-dependent activation mechanism of myosin light chain kinase.
    Krueger JK; Zhi G; Stull JT; Trewhella J
    Biochemistry; 1998 Oct; 37(40):13997-4004. PubMed ID: 9760234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeras of yeast and chicken calmodulin demonstrate differences in activation mechanisms of target enzymes.
    Nakashima K; Maekawa H; Yazawa M
    Biochemistry; 1996 Apr; 35(17):5602-10. PubMed ID: 8611552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of activity of chlorpromazine and respective hydroxy, dimethoxy and sulphoxide analogues on dopamine, muscarinic, histamine and calmodulin sites of action.
    Palmer GC; Blosser JC; McCreedy SA; Barrantes MA; Manian AA
    Xenobiotica; 1988 Mar; 18(3):277-89. PubMed ID: 2837873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Ca2+-dependent protein kinase and Ca2+/Mg2+-ATPase in cardiac sarcolemma by the anti-calmodulin drug calmidazolium.
    Lamers JM; Stinis JT
    Cell Calcium; 1983 Oct; 4(4):281-94. PubMed ID: 6139171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
    Agre P; Virshup D; Bennett V
    J Clin Invest; 1984 Sep; 74(3):812-20. PubMed ID: 6088585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.